The end of the coronavirus outbreak is looking more and more distant, but there at least comes some good news, in the form of more accurate diagnostics for 19-nCoV. And it’s a Nanjing company that we have to thank for this new tool in the coronavirus battle.
冠状病毒爆发的结束看起来越来越遥远，但至少有一些好消息，以更准确的19-nCoV诊断形式出现。 我们必须感谢这家南京公司在抗击冠状病毒时提供这个新工具。
Launched on 27 January, the new coronavirus diagnostic kit has been developed by Nanjing Geneseeq. Compared with existing products, the new kit can detect the full viral genome sequence data of 19-nCoV with a higher accuracy than existing products.
新的冠状病毒诊断试剂盒于1月27日推出，由南京Geneseeq开发。 与现有产品相比，新试剂盒可以检测19-nCoV的完整病毒基因组序列数据，比现有产品准确率更高。
According to a release by Dissemination Nanjing, the new product is at present going through emergency approval channels. It is hoped that sufficient kits can be prepared in the next 2 weeks so that they can be tested by 50,000 people.
根据南京传播的发布，新产品目前正在通过紧急审批渠道。 希望在未来2周内可以準備足夠的試劑盒，以便5萬人可以對其進行測試。
- Coronavirus is NOT in Nanjing’s Water Supply
- A Letter from the Nanjing Foreign Affairs Office
- Wuhan Flights Arrive in Nanjing; Infected Patients to Tangshan
Who or what is Nanjing Geneseeq?
南京Geneseeq是谁或是什么？
Founded by Shao Yang in 2008, Geneseeq is a next-generation sequencing (NGS) company, in the field of oncology precision medicine, based in Toronto, Canada.
Geneseeq由Shao Yang于2008年创立，是一家总部位于加拿大多伦多的肿瘤精准医学领域的下一代测序（NGS）公司。
Among other things, the firm provides genetic testing of rare diseases and cancer treatment solutions, based on the analysis of patients’ genes. Geneseeq translates this complex genomic information into meaningful decision-making tools for physicians, as such bringing precision medicine to cancer patients around the world.
除其他外，该公司根据对患者基因的分析，提供罕见疾病的基因测试和癌症治疗解决方案。 Geneseeq将这些复杂的基因组信息转化为医生有意义的决策工具，因此为世界各地的癌症患者带来精准医学。
The company’s laboratories are accredited by the College of American Pathologists (CAP) and are Clinical Laboratory Improvement Amendments (CLIA) certified.
该公司的实验室获得了美国病理学家学院（CAP）的认证，并获得了临床实验室改进修正案（CLIA）认证。
- Gloves More Important than Masks in Virus Fight, Experts Agree
- Snow, Food & Schools Latest Challenges Amid Wuhan Virus Outbreak
- 19 n-CoV Patient Movements Released in Search for others
Geneseeq operates out of the MaRS Discovery District in Toronto that was founded in 2000. As a life science incubator, MaRS aims to commercialise publicly-funded medical research with the assistance of local private enterprises.
Geneseeq在2000年成立的多伦多MaRS Discovery District运营。 作为一个生命科学孵化器，MaRS旨在在当地私营企业的协助下将公共资助的医学研究商业化。
In Nanjing, Geneseeq settled their Chinese headquarters in Jiangbei New Area in 2013. The company has developed 400 technology optimisation processes and more than 800 research and cooperation projects, making them leaders the field. According to Bloomberg, this China division collaborates with over 350 cancer-specialty hospitals in 24 provinces across China, providing tests to approximately 20,000 patients.
在南京，Geneseeq于2013年将其中国总部设在江北新区。 该公司开发了400个技术优化流程和800多个研究和合作项目，使他们成为该领域的领导者。 据彭博社报道，该中国部门与中国24个省份的350多家癌症专科医院合作，为约20,000名患者提供检测。
Nanjing Geneseeq produces the new coronavirus diagnostic kit in a 9,000 square-metre clinical testing centre and manufacturing facility. Over 700 employees work therein.
南京Geneseeq在9000平方米的临床测试中心和制造设施中生产新型冠状病毒诊断试剂盒。 超过700名员工在那里工作。
